Nephritis as a potential predictor of response to immune checkpoint inhibitors in kidney cancer
This study, to be published in Journal for Immunotherapy of [...]
γ-Glutamyltransferase as a biomarker in patients on nivolumab for metastatic kidney cacner
A protein called γ-glutamyltransferase can predict survival in patients with [...]
Treatment selection for metastatic kidney cancer based on gene expression
The discovery of a reliable biomarker for metastatic renal cell [...]
Biomarkers for avelumab plus axitinib in advanced kidney cancer
The discovery of a reliable biomarker for how patients with [...]
ESMO Virtual 2020: Circulating tumour DNA in metastatic kidney cancer patients
In a paper presented at this year’s European Society of [...]
ESMO Virtual 2020: Biomarker-guided therapy in metastatic kidney cancer
Yesterday, findings from the phase 2 biomarker trial, BIONIKK, were [...]
PBRM1 as a biomarker for kidney cancer
In this video interview, Dr Eric Jonasch from MD Anderson [...]
GRANT score for predicting disease-free survival in kidney cancer
In this retrospective study conducted at various hospitals in Italy, [...]
Biological markers of response for kidney cancer
To date, a reliable biomarker is yet to be discovered [...]
Association between TKI-induce high blood pressure and outcomes in patients with kidney cancer
In this retrospective study published in Cancer Reports the association [...]
